Advertisement Catalent takes over Aptuit clinical trial supplies business - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Catalent takes over Aptuit clinical trial supplies business

Catalent Pharma Solutions has completed the acquisition of the clinical trial supplies business of Aptuit.

The acquisition is expected to expand Catalent’s development & clinical services business and enhance its position in development solutions and advanced delivery technologies for drugs, biologics, and consumer health products.

Catalent’s development & clinical services business offers clinical supply solutions, analytical services for both small and large molecule drugs, inhaled and sterile product development, and regulatory consulting.